Organization | California State Polytechnic University, Pomona

California State Polytechnic University, Pomona Report issue

Academic/Hospital

Organization Overview

First Clinical Trial

2016

NCT02686905

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2023

Timeline

NOW

Now

Alternative names

California State Polytechnic University, Pomona | Cal Poly Pomona

Active Ingredients

Drugs in Other Trials (7)

calcium (1 trial)

chia seed (1 trial)

cyanocobalamin (berocca) (1 trial)

mango (1 trial)

multivitamins (1 trial)

vitamin d3 (1 trial)

vitis vinifera (1 trial)

Indications

Overview

Highest Phase: Phase 0
# of Trials: 4
# of Trial APIs: 7